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INTRODUCTION 
 Benign Prostate Hyperplasia (BPH) is a common disease in adult 
men and its incidence is age related. Prevalence of BPH is 
approximately 25% in men aged 40 to 49 years, 50% in men aged 50 to 
59 years and 80% in men aged 70 to 79 years.1 
                 Renal failure and symptomatic benign prostatic hyperplasia (BPH) 
are two common health problems, they usually  co-exist in 5.9–13.6% of 
the male population over 50 years of age. Actually going by the natural 
history of the disease and  its progression with relation to Benign prostatic 
hyperplasia and its complications, it is  noted that 13.6% of patients who 
presented to undergo Transurethral resection were in renal failure. It is 
usually not clear in this group of patients whether the reason for renal 
insufficiency is or is not Benign prostatic hyperplasia. However, it has 
been reported in some studies that the incidence of diabetes mellitus and 
hypertension is higher in patients with renal failure (RF) and lower 
urinary tract symptoms (LUTS) due to Benign prostatic hyperplasia. On 
the other hand, it is known that due to chronic urinary obstruction, BPH 
can lead to renal failure and even death occasionally. 
                The main constant indication for BPH surgery has been medical 
treatment-refractory moderate or severe Lower urinary tract symptoms; 
2 
 
but definite surgical indications usually includes upper urinary tract 
deterioration. Renal failure increases the risk in transurethral prostatic 
surgery, so there is a  tendency for avoiding the surgery till there is a  
detection of an absolute indication occurs. But these studies are based on 
data from two or three decades ago not representing current practice.  
 As we understand that these patients with BPH whether 
symptomatic or asymptomatic, if left untreated may present with renal 
failure which could be chronic or acute. Despite the many possible causes 
of renal failure in elderly patients, the common causes were BPH (38%), 
neurogenic bladder (19%), obstructive pyelonephritis (15%).2 
 While the underlying mechanism for developing renal failure 
associated with benign prostatic hyperplasia is likely multifactorial and 
co-morbid factors in elderly men may contribute to renal impairment, we 
wanted to evaluate the incidence of BPH with renal failure at our 
institute. 
 TURP remains the gold standard surgical procedure for treatment 
of these cases. However, patients in renal failure have an increased risk 
for complications after TURP compared with patients with normal renal 
function, so we wanted to study the treatment outcome and complications 
associated with its management. 
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 Attending to high prevalence of BPH in older men with CKD it is 
invaluable to take into consideration the relationship between these two 
clinical entities. However, despite the high prevalence of renal failure and 
BPH in elderly men, there is limited knowledge on the association 
between these two conditions, there is very little information in the 
literature  regarding the role of only BPH as a causative factor in causing 
renal failure and its treatment outcome.  
              The purpose of this study was to determine the incidence of renal 
failure associated with BPH , effect of TURP in the morbilidity and 
mortality of patients with renal failure. 
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AIMS AND OBJECTIVES 
 To study the prevalence of co-morbid factors in patients with 
Benign prostatic hyperplasia and  non dialysis requiring renal 
insufficiency.  
 Study of treatment outcome following the surgical management of 
BPH with non dialysis requiring renal failure. 
 Study of complications associated with operative management in 
these patients.  
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REVIEW OF LITERATURE 
Epidemiology of Benign prostatic hyperplasia : 
Benign hyperplasia of Prostate occurs with  increased growth of 
non malignant tissue of prostate which  surrounds urethra, it narrows the 
lumen of urethra and subsequently gives rise to symptoms.63 
Diagnosis of benign prostatic hyperplasia done conclusively on 
histological evaluation of prostate. Histological evaluation is by taking 
prostate by transurethral resection or trans rectal ultrasound guided or by 
doing autopsy. But other  measures, namely symptomatology, obstruction 
of bladder with associated enlarged prostate is  used to mark benign 
prostatic hyperplasia. Because of this, the  end point of benign prostatic 
hyperplasia becomes difficult to assess.  
These facts  gives us sufficient details about the newly occurring 
cases and disease progression.The prevalence of benign prostatic 
enlargement is  calculated by taking histological part (assessed by 
autopsy) or clinically. (3) No men 30yrs and younger had evidence of 
benign prostatic hyperplasia and the peak of prevalence increased along 
with each age group, ultimately reaching 88% in men with eighties.4 
Three things which are assessed separately which comprise of  
symptoms3; enlarged prostate with obstruction.5 It can present as all the 
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three or two of them or only one. Hence prostatism has been  now 
changed to lower urinary tract symptoms (LUTS).5,6 
 
                 
                            
                  Representative diagram showing relationship of various factors involved 
 
         Histologically, hyperplasia of prostate is seen in 8% men of age 31-
40. Whereas it increases to 90% of men in ninth decade.4,7. In the setting 
of Benign prostatic enlargement, untreated chronic kidney disease can 
result in ESRD requiring dialysis or kidney transplantation. 
Relationship between benign prostatic hyperplasia and Chronic 
Kidney Disease :       
Etiology of benign hyperplasia of prostate is largely unknown, but 
from clinical practice and studies, natural history of hyperplasia of 
prosate leads to urinary obstruction, landing in deterioration of renal 
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function with time. Both benign hyperplasia of prostate and chronic 
kidney disease are commonly prevalent in ageing male.  
           Following are the studies conducted to find relationship between 
Benign hyperplasia of prostate and chronic disease of kidney: 
a. Study conducted by  Epidemiology Project of Rochester, 
concluded that association was significant between  signs & 
symptoms of benign prostatic hyperplasia and Chronic kidney 
disease in their population-based sample which comprised of 
white men numbering 476.9 
b. But, another study conducted in Austria concluded that  Lower 
urinary tract symptoms in men was not an independent risk 
factor for impaired kidney function.10 
c. Another study that was conducted on  30,466 men study from 
the HUNT II (the Nord-Trondeleg Health Study), they also 
failed to show a connection between Lower urinary tract 
symptoms and Chronic kidney disease.11 
d. But recent evidence from two different studies have found out 
an association of bening hyperplasia of prostate and chronic 
disease of kidney.12,13 
Eventhough the prevalence of chronic kidney disease is considered 
to be low in men with benign hyperplasia of prostate, we should stongly 
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consider it in patients presenting with obstructive lower urinary tract 
symptoms mainly or with low peak flow rate or patients having 
hypertension or diabetes. 13 
Clinical guidelines for benign hyperplasia of prostate, which was 
created in 1994 by Health Care Policy and Research  Agency in 1994, 
recommended routine serum creatinine measurement in men with lower 
urinary tract symptoms, but in year 2003, a  update discontinued the 
routine  serum creatinine measurement in these persons.9 So these 
different approaches to benign prostatic hyperplasia patients, leads to a 
significant amount of patients with Chronic kidney disease going 
undetected. 
By taking this data into account, we should always  bear in  our 
minds that benign prostatic hyperplasia is almost an ubiquitous condition 
in the setting of old men. Low occurrence of chronic kidney disease in 
benign prostatic hyperplasia usually in clinical trials, should not be used 
to infer a weak association between the two disease processes. 
Signs and symptoms of Bladder outlet obstruction namely low 
QMax, high residual urine (post void), Obstructive symptoms of lower 
urinary tract  are significant predictors of chronic kidney disease.9,12 
Bladder outlet obstruction, probably, is  the bridge connecting between 
between chronic disease of kidney and benign hyperplasia of prostate.13 
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But we should never forget that chronic disease of kidney in the 
setting of benign hyperplasia of prostate is a multifactorial process, and 
thus  it becomes difficult to separate the contribution of this condition 
from all the other renal insults. This also affects and it takes its toll on the 
design of studies as many men with concomitant disease are excluded, 
and thus makes it harder for investigators,  to take into account the true 
influence of both these conditions. 
Pathophysiology and Progression of Benign prostatic hyperplasia : 
Although the etiology of benign hyperplasia of prostate is not 
known, there are similarities found between benign hyperplasia and 
morphogenesis of prostate during development. This prompted to suggest 
hypothesis that benign hyperplasia of prosate results due to reawakening 
of embryogenesis in adulthood.14 
Most common renal pathology finding in men with obstructive 
nephropathy with  benign prostatic hyperplasia is,  Chronic interstitial 
nephritis15, 9 and 30% of cases have been attributed to obstructive 
uropathy. End stage disease of  kidney secondary to bladder outlet 
obstruction can be prevented if  recognised early, however it is still 
difficult to recognise which men with benign prostatic hyperplasia can 
develop  renal failure. 
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 So we have to recognize factors which are measurable during 
evaluation of benign hyperplasia of prosate. This helps to prevent patients 
from developing renal failure. 
Anatomical  
 
      Benign hyperplasia of prostate initially in periurethral transition zone, then progressively enlarging 
 
          Benign hyperplasia of prosate develops first in periurethral 
transition zone of the prostate. This  transition zone has two separate 
glands located  external to the preprostatic sphincter. Benign prostatic 
hyperplasia also involves an increase in the number of glands, mostly the  
periuretheral glands increase in number, simultaneously there is a 
increase in  smooth muscle and connective  tissue in the periuretheral 
region of  prostate.16,3 
Physiological  
According to the physiological point, when the prostate enlarges, 
urethral compression occurs, which prevents the outflow of urine and 
contributing to the common lower urinary tract symptoms. Smooth 
muscle cells usually are not optimal for force generation. Non muscle 
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myosin heavy chain is upregulated along with down regulation of smooth 
muscle myosin heavy chain. These things  suggest that there is  loss of 
normal modulation pathways.16 
  We need to elucidate the factors determining passive tone in 
prostate.(3)Adrenergic system regulates the active muscle tone in 
prostate.(18) Adrenergic neurotransmitters have been involved in prostate 
smooth muscle regulation as well as contraction, and  α-adrenergic 
blockade actually leads  to a significant normal protein gene expression 
downregulation, specifically smooth muscle myosin heavy chain.19,3 
Clinical 
Studies conducted recently, found there was a significant 
correlation between urgency symptoms and prostate size.20 This also 
proves a link between Chronic disease of kidney and benign hyperplasia 
of prostate. Prostate size assessed by rectal examination is considered to 
have poor reliability, so trans rectal ultrasound of prostate is used in 
studies.3 
So, prostate and its benign enlargement can contribute for outflow 
obstruction, by two factors, one is the static component (periurethral 
compression caused by stromal component), the second one is also by 
dynamic component (smooth muscle cells and supplying adrenergic 
pathway).  
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BENIGN PROSTATIC HYPERPLASIA  
PATHOPHYSIOLOGY AND PROGRESSION : 
Disease progression :  
       Three things contribute, they are  Symtoms of lower urinary tract, 
Chronic retention of urine, Acute retention of urine.  
Lower Urinary Tract Symptoms (LUTS) 
         Lower urinary tract symptoms (LUTS) are described as clinical 
criteria to define a man with urinary problems. Most men with benign 
hyperplasia of prostate have following symptoms namely voiding 
dysfunction, nocturia, urgency, thin urinary stream, increased urinary 
frequency and a sense of incomplete bladder emptying. 
Many studies were done to achieve a scientific relation between 
Lower urinary tract symptoms and Chronic kidney disease. But, until 
recent years there was no palpable evidence mainly connecting these two 
entities. A retrospective study which was done to find this, did not find 
any relation between duration of symptoms and serum creatinine levels 
measured in these patients.21 
             Our clinical practice shows us that many men with Lower urinary 
tract symptoms routinely do not value their symptoms, and they avoid  
seeking medical care. Those older men often tolerate their symptoms and 
disregard their lower urinary tract symptoms avoiding consultation.22 
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            However we must take into account that the absence of these 
symptoms in older men does not necessarily exclude benign prostatic 
hyperplasia with urinary outlet obstruction. Silent prostatism or Silent 
obstruction, a term which describes asymptomatic patients developing 
chronic disease of kidney resulting from benign hyperplasia of prostate. 
So, International prosate symptom score will not be useful in these 
patients.23 
Post-voiding residual urine volume – Chronic urinary retention 
Chronic urinary retention is the mechanism, by which benign 
prostatic hyperplasia can result in  renal failure.9 Chronic retention of 
urine is  taken as  post-void residual urine (PVR),  higher than 100 mL. It 
is  significantly associated in Chronic disease of kidney.24,9,12  
Acute urinary retention 
Acute urinary retention is described as an acute complication of 
Benign prostatic hyperplasia. These patients suffer from an acute, sudden 
and painful inability to void. It needs emergency intervention. Acute 
urinary retention was the main indication of surgery in 25% and 30% of 
men undergoing trans urethral resection.3 Other causes that can trigger 
acute urinary retention are surgery, anaesthesia, trauma, medications, 
medical examination and urinary tract infections (mainly prostatitis). 
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Acute urinary retention is uncommon in men under sixty years, 
and may be responsible for the majority of acute renal failure cases due 
to obstructive uropathy.25 Men in whom acute urinary retention is 
promptly relieved by catheterizing the bladder,  acute renal failure 
usually does not develop but long-term tubular dysfunction can still 
occur.9 
 So, dysfunction of renal tubules can persist after the acute 
urinary retention episode and probably this might  result in progressive 
renal disease affecting these  patients. 
Pathophysiology  of  Progression to Renal failure 
Remodelling of Bladder in response  to urinary obstruction 
 
                                        
          Enlarged lateral lobes and median lobe of prostate producing bladder outlet obstruction with bladder   
                                    Trabeculations which leads to bilateral hydrouretreronephosis 
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 The bladder plays an important role in pathophysiology of benign 
hyperplasia of prosate and its complications. So, the bladder responds by 
adaptation, though it is a partial adaptation. Obstruction induces changes 
in bladder is closely related to symptoms rather than the obstruction by 
itself.  
Two types of bladder changes are observed. First is detrusor 
instability presenting with frequency and urgency and second one is 
decreased contraction of detrusor leading to poor stream, hesitancy, 
intermittency, increased residual urine. 3 
Thickened bladder is measured by ultrasound. Trabeculations due 
to hypertrophy of smooth muscle and permeation of connective tissue 
accounts for elevated bladder pressure in patients with high pressure 
chronic retention.26 
 The major detrusor changes and trabeculation were due to an 
increase in detrusor collagen. Severe trabeculation is directly related to 
significant post void residual urine27 suggesting that increases in  collagen 
in the bladder wall is mostly responsible for incomplete bladder emptying 
rather than impaired detrusor muscle function.3 
  Detrusor hypertrophy is one of the first and foremost modification 
in the bladder and, as studied in animal models, the response initially is 
the hypertrophy of smooth muscle.27 
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 Cellular and physiological changes that occur in bladder muscle 
and collagen, contributes  to  high pressure bladder that perpetuates itself 
with worsening ability to empty and causing kidney lesions. These 
mechanisms of bladder remodelling develop in a hypofunctional bladder, 
with low compliance.28 
Ureterovesical junction and upper tract dilation 
 
 
 
               
 
 
 
 
               Intravesical enlargement of prostate producing bilateral ureteric dilatation with ureterovesical junction                
                                                            obstruction and bladder trabeculations 
Generally, ureterovesical junction obstruction caused by 
remodelling of bladder in chronic urinary retention is a contributing 
mechanism for renal failure in benign prostatic enlargement.9 Upper tract 
dilation occurs as a consequence of a continuing bladder outlet 
obstruction and remodelling (detrusor hypertrophy and scarring) which 
leads  to anatomical ureterovesical junction obstruction.29 
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 Upper urinary tract dilation or hydronephrosis is consistent with 
chronic renal failure from obstructive uropathy. In men with benign 
prostatic hyperplasia and increased serum creatinine, hydronephrosis is 
common in about one third of patients, but it is found in 90% of men with 
benign prostatic hyperplasia who are hospitalized with uremic 
symptomatology. In ultrasound evaluation, it is common among patients 
with bilateral hydroureteronephrosis, leading on to compression and renal 
cortical thinning, with obvious impact in renal function.23 
Other causes 
- Recurrent urinary tract infections with chronic retention due to 
benign hyperplasia of prostate may be a contributing factor leading 
on  to chronic renal failure.9 
- Other cause being, Secondary hypertension occurring due to 
chronic urinary retention is a described complication of benign 
prostatic hyperplasia, leading to hypertensive kidney disease.30 
- Nephrogenic diabetes insipidus can be caused by partial or chronic 
urinary obstruction, this  can result in renal failure.31 
Other clinical entities like diabetes and hypertension are 
independent factors that can lead to chronic kidney disease.(32)  
Patients with benign prostatic hyperplasia are usually  carriers of 
these pathologies above mentioned that are likely to seriously aggravate 
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renal function and must be taken into account as sombre conditioners of 
renal disease. 
Clinical symptomatology : 
Benign prostatic hyperplasia is a chronic and progressive 
condition,(33) where in patients generally have a history of lower urinary 
tract symptoms and indolent obstructive uropathy. The clinical 
presentation of benign hyperplasia of prostate  and associated obstructive 
uropathy varies and this reflects the source and duration of obstruction. In 
benign prostatic hyperplasia, symptoms directly results from bladder 
outlet obstruction (BOO) from prostate enlargement which is static 
component dynamic component by enhanced smooth muscle tone and 
increased resistance within the gland. 
These physiologic issues reflect in voiding dysfunctions, that 
significantly affects the health and quality of life of older men. Most of 
the patients have characteristic symptomatology. 
Patients complaints are usually thin urinary stream, nocturia, 
urgency, with decreased flow rate, low values in Qmax and Qaverage, a 
sense of incomplete bladder emptying, straining during micturition, 
increased urinary  frequency and dribbling during or after urination.9 
 Physical examination consists of digital rectal examination 
(assesses the prostate characteristics and volume), bladder distension by 
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lower abdominal percussion and palpation and focused neurological 
examination to rule out neurogenic component involved in the 
presentation. 
Recurrent or persistent urinary tract infections (UTI) which are 
associated with prolonged urinary stasis of lower urinary tract 
obstruction, urgency, frequency, dysuria, hematuria are common 
complaints among men with Urinary tract infection. 
Chronic urinary retention due to benign hyperplasia of prostate is 
defined as a palpable bladder, corresponding  to  high post void residual 
urine34 and most of these patients with chronic urinary retention have an 
indolent and progressive disease, with worsening of urinary symptoms 
and the majority of these patients just seek for medical care in worsening 
health conditions with acute renal insufficiency. 
  It becomes necessary to investigate the  symptoms and signs  
suggesting chronic kidney disease  like vomiting, nausea, edema, 
lethargy,hypertension.23  
 In some rare cases of patients who present to the emergency room 
because of anuria, require interventional procedures like indwelling 
catheter, nephrostomy tube insertion either unilaterally or bilaterally and 
sometimes depending on the level of renal function, hemodialysis may be 
required. 
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Even though the  signs and symptoms of benign hyperplasia of 
prostate are normally present in a group of patients, there are a significant 
number of patients who are relatively asymptomatic35 (without significant 
voiding dysfunction), but can present primarily as a clinical sequel of 
renal insufficiency namely uremic symptoms; with vomiting, nausea,  
mental status changes and electrolyte disturbances namely  hypercaliemia 
and nonanion gap acidosis. 
Older patients with voiding dysfunctions caused by chronic urinary 
obstruction might present with hypertension due to hypervolemia in the 
case of bilateral obstruction or increased renin release.35 Hypertension, on 
other hand can be itself the sole cause of renal failure. 
 If left untreated, benign prostatic hyperplasia can cause serious 
complications including hematuria, urinary tract infections, renal failure, 
bladder stones, incontinence and mortality related with benign prostatic 
hyperplasia. 
Complications in Patients with  Benign hyperplasia of prostate : 
Mortality : 
Patients with renal failure undergoing transurethral resection have a 
higher risk (25%), in comparison to normal renal parameters (17%), 
whereas mortality increases sixfold. 
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Bladder stones 
Bladder stones occur in line with  retention of urine leading on to  
stasis and urinary infection. These factors favour ion aggregation and 
stone nucleation. This leads on to formation of vesical calculi. 
Urinary tract infections 
Urinary tract infections are usually due to chronic urinary 
obstruction, due to increased post void residual urine, predisposing  to 
Urinary tract infections.39 This leads to multiple hospital admissions for 
treating these urinary tract infections. 
Incontinence of Urine 
Incontinence can develop from transurethral surgical intervention 
for benign prostatic enlargement 40. Other causes are overflow incontinece 
due to overdistention of the bladder or due to  instabilityof detrusor 
resulting in urge incontinence.41,42,3 
Hematuria 
Gross hematuria with clots can be seen in  patients with benign 
hyperplasia of prostate. Microvessel density in prostate is higher in 
hematuria patients than in controls3 suggesting that vascular lesions in the 
prostate. 
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Tests for diagnosing the condition : 
Nowadays it is increasingly rare to find a patient with chronic renal 
failure from chronic urinary retention due to benign prostatic hyperplasia, 
about 13.6% (range from 0.3 to 30%) of men with benign prostatic 
hyperplasia may present with chronic kidney disease defined by a 
baseline serum creatinine of more than 133 mmol/L (1.5 mg/dL). This is 
particularly true in older patients with cognitive deterioration and 
autonomy impairment. 
         In order to diagnose and monitor the impact of a bladder outlet 
obstruction due to benign prostatic hyperplasia in the upper urinary tract, 
some laboratory and imaging tests:  
 Standardized questionnaires 
 Creatinine levels in serum or measuring estimated glomerular 
filtration rate (eGFR) 
 Urine analysis 
 Serum prostatic specific antigen (PSA) levels 
 Uroflowmetry with peak flow rate determination (Q max) 
 Renal and bladder ultrasonography with detrusor thickness 
evaluation 
 Transrectal prostate ultrasonography with measurement of prevoid 
urine  and post-void residual urinary volume 
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 Cystometry, other urodynamic studies as needed  
 Urethrocystoscopy. 
Symptom assessment by standardized questionnaires 
Benign prostatic hyperplasia Impact Index (BII),  a questionnaire 
assessing  symptoms effect in everyday, daily activities interference, so 
informing us the impact of benign hyperplasia of prostate. This can be 
used with International prostate symptom score.(American Urology 
Association 2010). 
Symptom quantification is useful for diagnosis, determination of 
disease severity and monitoring of benign prostatic hyperplasia. 
International Prostate Symptom Score is the  standard got from the 
American Urological Association Symptom Index published in 1992.43 
A recent multivariate analysis, found relationship between 
individual symptoms in theis questionnaire and chronic kidney disease 
status. They found that obstructive symptoms like poor stream and 
hesitancy were associated significantly with chronic kidney disease in 
age.44 Where as Irritative symptoms had no positive correlation with 
chronic kidney disease. Moderate to severe Lower urinary tract 
Symptoms (IPSS > 7) were positively correlated with chronic kidney 
disease.9 Kidney failure risks were higher for men with moderate,  severe 
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Lower urinary tract Symptoms compared with men with no or mild 
Lower urinary tract Symptoms.11 
Kidney function decreases with age and age significantly correlates 
with Symptoms of lower urinary tract.10 
Although symptom score assessment do not directly correlates with 
chronic kidney disease or can’t be used to establish the diagnosis of 
benign prostatic hyperplasia, it may serve as a basis for symptom severity 
and management approach to patients with Symptoms of lower urinary 
tract. Further testing should be considered in patients with an IPSS.  
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Serum creatinine 
American Urological Association 2010 Guidelines do not suggest 
routine serum creatinine measurement in management of benign 
hyperplasia of prostate. This recommendation is based on the conclusion 
that  renal insufficiency is no more common in men with benign prostatic 
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hyperplasia than in men of the same age group belonging to  general 
population. 
But, the European Association of Urology Guidelines on benign 
prostatic hyperplasia (2004) and the nephrology-focused NICE (National 
Institute for Health and Clinical Excellence) guidelines advocated 
measuring serum creatinine levels in all  patients. This is relied on the 
fact, that bladder outlet obstruction due to benign prostatic enlargement 
can cause hydronephrosis and renal failure.23 
 Patients with benign prostatic enlargement and renal insufficiency 
have relatively higher postoperative complications (25% complication 
rate compared with 17% for patients without renal failure) and mortality 
goes up to sixfold  than those with normal renal function.37,38, 45 Estimated 
glomerular filtration rate (eGFR) is a much more reliable measure to 
define chronic kidney disease and is better than simple serum creatinine 
measurement.46 
Urinalysis 
Urinalysis is an inexpensive and simple test that is recommended 
as a primary evaluation of a patient with suspected benign prostatic 
enlargement. It is used to rule out urinary tract infection and hematuria. 
On the other hand, the finding of proteinuria  and/or  micro- albuminuria 
can be suggestive of renal failure. 
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Measuring Total PSA (Prostate specific antigen): 
Total PSA is to be offered to patients with more than ten years of 
life expectancy and in whom measuring Prostate specific antigen will 
change the management of the lower urinary tract symptoms (AUA 2010 
Guidelines). Combining digital rectal examination (DRE) and total PSA 
measurement becomes  the  cornerstone of basic screening of prostate. 
The risks of requiring surgery and developing acute retention is based on 
measuring PSA and prostatic volume. 
Usage of Uroflowmetry ( Peak urinary flow rate ) 
Uroflowmetry is a noninvasive, simple  urodynamic test that 
allows us to have a  objective evaluation of the patient micturiating 
pattern. Although uroflowmetry is an non specific evaluation tool, the 
micturition graph may suggest some recognizable patterns (e.g. meatal 
stenosis, urethral stricture, benign prostatic hyperplasia) and it is a tool 
which is  reproduced  to quantify the urinary stream strength. It is a useful 
preoperatively. Peak urinary flow rate (PFR), or Qmax, predicts surgical 
outcome – by suggesting that, in patients with a preoperative Peak flow 
rate  more than 15 mL/s have poorer outcomes than patients with lesser 
peak flow rate. It is also an independent predictor for chronic kidney 
disease rather than reported Lower Urinary Tract Symptoms by 
standardized questionnaires.13,9 
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                          Uroflowmetry. A) Normal patient; B) BENIGN PROSTATIC HYPERPLASIA patient 
Ultrasound of kidney,ureter, bladder : 
Patients with an elevated serum creatinine level, increase post-void 
residual urine volume are candidates requiring ultrasound of kidney.47 
Renal ultrasonography has many advantages over intravenous urography 
(IVU) for upper urinary tract. It can measure and evaluate bladder, post-
void residual urine volume and prostate, better characterization of  renal 
masses if found, no harm of  radiation, no side-effects and lower cost. 
     
             Renal Ultrasound. Two ultrasound scans in benign prostatic hyperplasia patient showing bilateral   
                                  hydroureteronephrosis (right and    left kidney respectively)  
Bladder ultrasonography 
               Measuring bladder wall thickness by transabdominal ultrasound, 
it is  a method to assess bladder outlet obstruction.49 Measurement of 
detrusor wall thickness at the anterior wall of bladders having 250 mL 
29 
 
can detect bladder outlet obstruction, if it is more than 2 mm.(50)  But it is 
not recommended by guidelines as it lacks reproducibility. 
       
Bladder Ultrasound. Two ultrasound scans in benign prostatic hyperplasia patient. It is possible to observe the   
                                    trabecullation, bladder wall thickening and diverticulum 
Evaluation of Post-void residual urine: 
Post-void residual urine volume can be measured non invasively 
by  transabdominal ultrasonography.(41) It can also be measured by 
invasive methods  like catheterization. Residual urine volumes  more than 
300 mL affect renal function in cases of  benign hyperplasia of 
prostate.51,9 Post Void Residual urine  more than 100 mL is  chronic 
retention of urine  which is  associated with chronic kidney disease.9 
Even residual urine volumes less than 100 mL can affect renal function as 
the presence of residual urine in post void period is  related with renal 
function regardless of the quantity. Thus ultrasonographic evaluation of 
post-void residual urine is a useful test in the prevention of chronic 
disease of kidney.  
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Transrectal ultrasonography of Prostate : 
Transrectal ultrasonography of prostate (TRUS) is performed for 
asssessing prostate size and shape, tissue characterization and carcinoma 
prostate. There is no relationship between prostatic enlargement measures 
and chronic kidney disease.9 
Ultrasonographical Tranabdominal grading of prostatomegaly: 
Grade I - 3.0 to 3.8 cms, 30 Gms. Grade II - 3.8 to 4.5 cms, 30- 50 Gms. 
Grade III- 4.5 to 5.5 cms, 50- 80 Gms. Grade IV - 5.5. cms, 80 Gms.3 
 
             Prostate Ultrasound. Prostate transrectal ultrasonography (sagital view) 
Cystometry 
It is usually not a routine examination for benign prostatic 
enlargement evaluation. However, it can help to identify high bladder 
pressure, low bladder compliance and detrusor instability that can 
considerably affect renal function.9,12 
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Use of Urodynamics : 
Urodynamics is mainly  useful for distinguishing between bladder 
outlet obstruction and  impaired contraction of detrusor. It is performed if 
it is going to affect the therapeutic decision. Patients with history of 
neurologic diseases known to affect bladder or sphincter and patients 
with bothersome symptoms with peak flow rate more than 15 ml/s may 
benefit. 
Urethrocystoscopy 
Urethrocystoscopy is  not  to be done routinely but is optional if 
invasive treatment is contemplated.41,43 This also can confirm, other  
causes of outflow obstruction, sametime eliminating intravesical 
pathologies. 
                             
                   Cystoscopic view showing enlarged lateral lobes of prostate and verumontanum 
 
Aspect of Treatment : 
Patients with mild symptoms are managed by watchful waiting, 
patients with moderate symptoms should receive pharmacotherapy and 
patients with severe bother benefit the most  from surgical management. 
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So, a  man with preoperative IPSS   more than17,  has 87% chance of 
having symptom reduction.52 
We have to identify a  group of patients who are at increased risk 
of progression (e.g. age, symptoms, Prostate specific antigen level, 
Qmax, volume of prostate  and post-void residual urine). Here we have to 
give  early preventive treatment.53,50 Because, a higher frequency of 
kidney failure in patients presenting for prostate surgery than for non 
prostate surgery has been shown, and several studies have shown 
improvement in kidney function after prostatectomy.21 
Emergency situations : 
Patients who present to the casualty,  with bladder outlet 
obstruction and high serum creatinine, they should first be put in a  
urethral catheter and subsequently they need to be evaluated to 
distinguish between, whether it is an acute and chronic renal failure. 
Hospitalization is required in these cases. If hydroureteronephrosis and 
azotaemia persists despite decompressing the bladder, we should suspect 
an ureterovesical junction obstruction and the next step would be bilateral 
percutaneous nephrostomy or bilateral double J stents if possible, these 
are done for temporarily drainage. Patients further may need urgent 
hemodialysis. Ureteroneocystostomy after a prostate ablation may be 
adequate for definite ureterovesical junction obstruction resolution. 
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Benign prostatic hyperplasia - Medical treatment : 
Medical approaches are not used to treat if complications are 
associated with benign prostatic hyperplasia (one of them is  chronic 
kidney disease). They are used for Lower urinary tract symptoms relief 
and for preventing the progression of benign prostatic hyperplasia 
(especially 5 alpha reductase inhibitors - 5-ARI).It is also  useful in 
preventing benign prostatic hyperplasia complications such as chronic 
kidney failure. However, they can’t revert chronic kidney disease 
secondary to benign prostatic hyperplasia.  
Surgical treatment 
 Surgical treatment is mainly offered to men developing 
complications from benign hyperplasia of prostate. Health Care Policy 
and Research agency and International Consensus Guidelines, 
recommend surgery if patient has  
1. refractory urinary retention (patient failing atleast one catheter 
removal attempt) 
2. Following conditions  secondary to benign prostatic 
hyperplasia- recurrent Urinary tract infection, bladder stones, 
recurrent gross hematuria,  renal insufficiency,  large bladder 
diverticula.40 
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 Some studies suggest that dialysis dependent patients may recover 
renal function up to a year after prostatic surgery. Here  efforts should be 
made to identify and treat benign prostatic hyperplasia in patients under 
dialysis. 
Erectile dysfunction in about 4% to 10% and urinary incontinence 
in 0.5% to 1.5%  can develop in postoperative period.54,42 Recurrence of 
benign hyperplasia of prostate following surgery at five years is about  
2% to 10%. 
Standard surgical procedures 
Transurethral resection of the prostate is the standard and gold 
standard in the sugery for Benign hyperplasia of prostate. Other 
procedures are compared against this.55 
Complications of Transurethral resection of Prostate :56 
Patients with renal failure undergoing procedure need attention as the 
complication rates increase in this group including mortality. The 
complications of TURP are enumerated as follows : 
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                           Intra-operative and peri-operative complications of TURP56 
 
 
                                         Main late post-operative complications of TURP56 
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Complications  
Bleeding 
Arterial bleeding  is more noticed in cases with  preoperative 
infection, retention of urine due to gland getting congested. Antiandrogen 
preoperatively can help in decreasing bleeding. Venous bleeding due to  
perforation of capsule and opening of venous sinusoid during surgery. 
The amount of intraoperative bleeding  usually depends on size of 
prostate gland and amout resected. 
Extravasation 
 If bladder neck division occurs or  capsule perforated, 
extravasation  occurs. It is usually extraperitoneal, but if bladder injured 
or diffusion occurs in large volume, it can become intraperitoneal. 
Injury to Ureteric orifices : 
It can occur during large median lobe resection where it becomes 
difficult to identify ureteric orifice. Treatment depends on severity. 
External sphincter injury : 
            Injury occurs mostly at ventral area ( at 12’0 clock postion) 
because we cannot visualize verumontanum. But if verumontanum is 
already resected, the sphincter injury risk increases. 
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Postoperative complications57 
Bladder tamponade 
Evacuation of clots due to recurrent or persistent bleeding or 
reintervention occurs in 1.3–5% patients. Changing of colour from clear 
to red intermittently in irrigation suggests arterial bleeding, whereas 
venous bleeding usually results in a irrigation fluid continuously showing 
dark red colour. 
Infection 
The infection rate is usually low .Risk factors for infection : 
- Preoperative bacteruria 
- Duration of  procedure exceeding 70 min 
- Tamponade evacuation  
 - Preoperative stay longer than two days 
Retention of Urine : 
It occurs in 3–9% of patients. Mostly due to detrusor failure rather 
than, incomplete resection. It is advised not to go for resurgery till 
prostatic fossa is healed, exception is if transrectal ultrasound showing 
significant tissue like ventile effects. 
Incontinence postoperatively 
Early incontinence occurs in 30–40% of patients, but late 
iatrogenic stress incontinence occurs in less than 0.5%. 
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Urethral stricture58 
Literature suggests 2.2% to 9.8% occurrence and no relationship to 
time present. The locations and reasons are 
-Meatal strictures occurs due to inappropriate size of the instrument and 
the diameter of meatus. 
-Bulbar strictures are due to inadequate isolation by the lubricant, so 
monopolar current leaks. We need to apply gel in urethra and along 
resectoscope shaft. Reapply the gel if procedure is long. Avoid high 
cutting current. Perform internal urethrotomy if meatus narrowed or 
stricture present. 
 Bladder neck stenosis 
                    It is around 0.3% to 9.2% in incidence, more with lesser than 
30g gland resection. Prophylactic bladder neck incision while concluding 
procedure may decrease incidence. Once it develops, treatment is by 
incision by laser or electrical current. 
Retrograde ejaculation 
Avoiding of tissue around bladder neck leads to reduced incidence. 
Especially in younger patients, try medical treatment. Transurethral 
incision leads to reduced incidence. 
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Erectile dysfunction 
Around 3.4% to 32% develop erectile dysfunction. High frequency 
current applied close to the capsule damages neurovascular bundle.  
Recurrent BENIGN PROSTATIC HYPERPLASIA 
Usually due to insufficient resection or natural course of disease, 
but it is lesser with  TURP than Transurethral microwave therapy and 
Trans urethral needle ablation.  
TUR syndrome59 
It is around 2% risk that  TUR-syndrome develops. It is due to 
fluid intoxication, serum sodium level less than 130nmol/L. Large glands, 
venous sinus opening, prolonged resection time, smoking history increase 
risk. 
Post-obstructive diuresis  
            Marked natriuresis along with water excretion characterize this 
disorder. In addition other serious electrolyte disorders such as 
hypokalemia, hyponatremia and hypomagnesemia can occur. 
 The etiology is multifactorial, related to fluid and urea 
accumulation in  obstruction and  tubular resistance to  aldosterone and 
antidiuretic hormone.  
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 Treatment by fluid replacement with 0.45% saline, at a rate 
slightly less than urine output and replacement of electrolytes as they are 
needed. 
Renal recovery61,62 
 Complete or prolonged partial urinary tract obstruction leads to 
tubular atrophy and eventually  irreversible renal injury. Prognosis after 
relief  of obstruction is depends on duration, severity of obstruction. 
Complete recovery of glomerular filtration rate occurs  if  relieved within 
one week, but little or no recovery, occurs after 12 weeks. 
 However, measurement of the Glomerular Filtration Rate probably 
overestimates the true degree of recovery. In a rat model in which 
complete unilateral ureteral obstruction was induced for  24 hours, 
approximately 15 percent of nephrons were nonfunctional as late as 60 
days after release, a presumed reflection of irreversible injury .Despite 
this nephron loss, the Glomerular filtration rate can return to normal 
because of hypertrophy and hyper filtration in the remaining functional 
nephrons. It is likely that a similar process of compensatory hypertrophy 
occurs in human obstruction, as  it has been demonstrated in other 
diseases such as lupus nephropathy. The course of partial obstruction is 
less predictable.  It clearly depends on the severity and duration of the 
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obstruction, as well as other potential complicating factors, such as 
hypertension, infection, or preexisting renal disease.  
Functional recovery61,62 
          Radionuclide scanning and renal ultrasonography have been used 
in an attempt to predict the likelihood of functional recovery. Adverse 
prognostic findings thought to be indicative of severe and usually 
irreversible disease include total nonvisualization on renal scan and 
marked cortical thinning on ultrasonography.  
But, these findings may not be useful in the individual patient, 
since their presence does not preclude substantial return or even near 
normalization of the GFR following release of the obstruction  
Most of the functional recovery will usually be seen in the first 7 to 
10 days after relief of the obstruction. However, some patients with 
severe renal failure may, after the obstruction is relieved, require dialysis 
for a period of weeks until sufficient improvement occurs to allow 
dialysis to be discontinued.  
Only partial recovery is seen in this setting with the plasma 
creatinine concentration generally stabilizing at a value above 3 mg/dL 
(264 µmol/L). 
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MATERIALS AND METHODS 
Study Design : Prospective study 
Duration : August 2012 to Dec 2013 
Setting : Govt. Stanley Medical college and Hospital, Chennai, 
This is a clinical study of 40 cases of Benign prostatic hyperplasia in 
normal and   in patients with non dialysis requiring renal failure who 
underwent surgical therapy-TURP. 
PATIENT SELECTION 
INCLUSION CRITERIA 
All patients with Non dialysis requiring Renal Dysfunction  
associated with  Benign Enlargement of Prostate in the Department of 
Urology in our institute.  
EXCLUSION CRITERIA 
 Histologically proven malignant prostatomegaly 
 Patients undergoing open prostatectomy 
 Patients with end stage renal disease requiring hemodialysis. 
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DATA COLLECTION 
         This is a clinical study of 40 cases of BPH who underwent surgical 
therapy – Transurethral resection of prostate in our institute, out of which 
20 patients presented with elevated renal parameters. 
            The screening was done by selecting all the patients presenting 
with BPH (350 patients) at our institute during the study period, out of 
which patients who had associated renal failure on the basis of serum 
creatinine value were selected. Serum creatinine level of greater than 
1.4mg/dl was taken as criteria to determine the presence of renal failure. 
Among the patients who had BPH with renal failure cases which satisfied 
the inclusion criteria (20 patients) were selected and rest of the cases i.e. 
cases which required dialysis, prostatic malignancy, causes of obstructive 
uropathy other than BPH were filtered out. 
 All the patients in the study group presented to our institute with 
severe obstructive voiding symptoms including retention of urine who 
underwent urethral catheterization and residual urine were measured. All 
the patients underwent ultrasound abdomen, some of the patients before 
and some after catheterisation.  
Serum Prostate Specific Antigen (PSA) levels were done only in 
patients with suspicious finding on digital rectal examination. 
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Urodynamic study was done in selected patients to rule out neurogenic 
bladder. After the stabilization of renal function (RFT) all the patients 
underwent diagnostic Cystoscopy followed by TURP. Indwelling 20 Fr 
three way Foley’s catheter was inserted which was removed on 4th  post 
operative day. Patients who went for retention after catheter removal 
were re catheterised and check cystoscopy done later to rule out the 
possible obstructive causes of retention. Patients who voided successfully 
were discharged. Histology of the resected prostate confirmed benign 
prostatic hyperplasia in all cases. 
 In the post operative period Serum creatinine estimation was done 
on 2nd,7th day and at 6weeks. Ultrasound was done 6 weeks post 
operatively.Patients with non dialysis requiring renal insufficiency and 
normal patients were grouped as groups 1 and 2, respectively.Patient age, 
comorbid diseases,  IPSS, residual urine volume, prostate volume, urea, 
creatinine ( at presentation, post cathetrisation), Sodium, potassium, 
hemoglobin levels recorded preoperatively. Bleeding time and clotting 
time done preoperatively in all patients to rule out any coagulation 
abnormality.If any patient in group 1 shows a drop of s.creatinine below 
1.4 in the post cathetrisation setting, they were shifted to group 2 along 
with normal patients. 
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Transurethral resection of prostate was performed using a 24 
French Storz resectoscope and 1.5% glycine solution or with normal 
saline (bipolar). Regional anaesthesia was employed. Early postoperative 
values of hemoglobin, Na, K, and creatinine levels which were measured 
24 hours after the operation were recorded. The need for blood 
transfusion and presence of a TUR syndrome were also evaluated. The 
catheters of the patients were removed in 4th Postoperative day after the 
urine became clear.  
                                   DATA ANALYSIS: 
STATISTICAL METHODS APPLIED 
Frequencies 
The Frequencies procedure provides statistics and graphical displays that 
are useful for describing many types of variables. The Frequencies 
procedure is a good place to start looking at your data. 
Descriptives 
The Descriptives procedure displays univariate summary statistics for 
several variables in a single table and calculates standardized values (z 
scores). Variables can be ordered by the size of their means (in ascending 
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or descending order), alphabetically, or by the order in which you select 
the variables (the default).  
Chi-Square Test 
The Chi-Square Test procedure tabulates a variable into categories and 
computes a chi-square statistic. This goodness-of-fit test compares the 
observed and expected frequencies in each category to test either that all 
categories contain the same proportion of values or that each category 
contains a user-specified proportion of values. 
Crosstabs (Contingency coefficient test) 
The Crosstabs procedure forms two-way and multiway tables and 
provides a variety of tests and measures of association for two-way 
tables. The structure of the table and whether categories are ordered 
determine what test or measure to use.  
Paired samples t test 
The Paired-Samples T Test procedure compares the means of two 
variables for a single group. It computes the differences between values 
of the two variables for each case and tests whether the average differs 
from 0. 
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Independent-Samples T Test 
The Independent-Samples T Test procedure compares means for two 
groups of cases. Ideally, for this test, the subjects should be randomly 
assigned to two groups, so that any difference in response is due to the 
treatment (or lack of treatment) and not to other factors. 
All the statistical calculations were done through SPSS 16.0 (2007) for 
windows. 
Multinomial Logistic Regression 
Multinomial Logistic Regression is useful for situations in which you 
want to be able to classify subjects based on values of a set of predictor 
variables.  
Pearson’s correlations coefficient 
The Bivariate Correlations procedures computes Pearson’s correlations 
coefficient. Correlations measure how variables or the Rank orders are 
related. 
The statistical operations were done through SPSS 16.0 (2007) for 
windows and EPIINFO software 
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OBSERVATION AND RESULTS: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TotTotal No. of patients screened for BPH 
attending our institute- Government Stanley 
Medical college and Hospital, during the study 
period between August  2012-Dec 2013 
                               350 
 
• Total BPH=678 
Among patients with BPH, patients 
with renal failure were selected  
                         61 
Among these patients, 20 patients who 
had renal failure (S.Creatinine 1.4 to 3) 
associated with BPH  and those who 
underwent TURP  and 20 patients 
randomnly selected from normal pool 
who underwent TURP were taken. 
                  
Patients without renal 
failure i.e. Sr.Creatinine 
< 1.4 were excluded 
Exclusions: 
 
 Prostatic Malignancy 
 Cases selected for Open 
prostatectomy 
 Cases requiring hemodialysis 
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     In our study total of 350 patients at our institute were screened during 
the study period and 20 of those patients who satisfied the inclusion 
criteria were included in the study group. The observation and results of 
the study were as follows.       
1.Descriptive Study 
Table 1.0. Age Distribution of study population : Group 1  
 
 
   
 
 
 
                                   
 
 
 
                                             Age distribution pattern in Group 1 patients 
Age 
(in yrs) 
No. of 
patients  
Percentage 
51-60           5 25% 
61-70 11 55% 
71-80 4 20% 
81-90 0 0% 
Total 20 100% 
Group N Mean 
Std. 
Deviation P value 
Age in 
years 
Group I 20 65.00 5.620 
0.620 Group 
II 
20 64.00 6.959 
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In a total of 20 patients in Group 1, the youngest was 55 years and oldest 
was 75 years with a mean age of 64 years and standard deviation of 5.62 
with the predominant age group 61-70 years. 
In Group 2, 
 
 
 
 
 
                                  Age distribution pattern in Group 2 patients\ 
    In Group 2, the youngest patient was 52 years and oldest patient was 
76 years with a mean of 64 years with a standard deviation of 6.95. 
 
 
 
 
 
Age 
(in yrs) 
No. of 
patients  
Percentage 
51-60           8 40% 
61-70 7 35% 
71-80 5 25% 
81-90 0 0% 
Total 20 100% 
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Group 1 
                        
                                 Figure 1. Frequency distribution of population in Group 1 
   In  Group 2 
                   
                               Figure 1. Frequency distribution of population in Group 2 
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Symptom score and Quality of Life 
 N Minimum Maximum Mean Std. 
Deviation 
IPSS 
Group 1 
 
20 
 
  20 
24.95 1.986 .444 
Group 2 20 20 24.65 1.899 .425 
                                 Table 1.3. Symptom score  
All the patients had severe IPSS (majority had obstructive symptoms) 
with a mean score of 24.95 in Group 1 and 24.65 in Group 2,minimum 
and maximum score of 20 and 25 respectively with a standard deviation 
of 1.98. On analysis of IPSS score it was found that mean obstructive 
symptoms score was 14.3 as compared to the mean irritative symptoms 
score of 10.5.  
                
                                       Figure 3. IPSS score in this study population  
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                                 Figure 4. IPSS score (obstructive vs. irritative score) 
 
Comorbities associated with groups  
          In Group 1, out of 20 patient who presented, nine people had 
comorbidities, where as in goup two eight people had comorbidities. 
The difference between these two groups was not significant.  
 
       Correlation between comorbidities like hypertension, diabetes in both groups 
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   Group Total 
    Group I Group II   
Comorbities Nil Count 11 12 23 
    % within 
Comorbities 
47.8% 52.2% 100.0% 
    % within Group 55.0% 60.0% 57.5% 
  HT Count 3 3 6 
    % within 
Comorbities 
50.0% 50.0% 100.0% 
    % within Group 15.0% 15.0% 15.0% 
  DM Count 5 4 9 
    % within 
Comorbities 
55.6% 44.4% 100.0% 
    % within Group 25.0% 20.0% 22.5% 
  Both Count 1 1 2 
    % within 
Comorbities 
50.0% 50.0% 100.0% 
    % within Group 5.0% 5.0% 5.0% 
Total Count 20 20 40 
  % within 
Comorbities 
50.0% 50.0% 100.0% 
  % within Group 100.0% 100.0% 100.0% 
              Correlation of comorbidities both within the group and between the two groups 
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Ultrasound prostate size : 
            Comparing the prostate size by ultrasound in both groups, the 
mean prostate volume was 46cc in group 1 with a standard deviation of 
12.47 and 42 cc in group 2 with a standard deviation of 14.19. 
Residual urine measurement : 
          When we compare the residual  urine in both groups, residual urine 
in patients in group1 was in the range of 165 ml and in group 2 it was in 
the range of 136ml. 
S.creatinine at presentation : 
          In group 1, patients who presented with elevated s.creatinine 
values, the following values were recorded at presentation 
 
Picture representing levels of S.creatinine in patients during presentation 
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         It ranged from 3.4 to 1.7, with a mean value of 2.170 and a standard 
deviation of 0.5. All these patients underwent catherization accordingly, 
then their s.creatinine was recorded once it got stabilized. Whereas in 
group 2, the mean serum creatinine was around 0.925 with a standard 
deviation of  0.1. 
Preoperative Serum creatinine : 
       Once the serum creatinine values stabilized, the readings were 
recorded. Out of 20 patients who presented with elevated renal 
parameters, (patient with s.creatinine more than 1.4 )  five patients 
subsequently showed fall in serum creatinine below 1.4, hence were 
considered along with normal patients in group 1. Because of this, the 
subsequent serum creatinine values of rest of 15 patients stabilized at a 
mean of 1.7 with a standard deviation of 0.3.  Interestingly patients whose 
serum creatinine which stabilized at a value of more than 1.4, some of 
them had coexistent diabetes, hypertension. This might be an explanation 
that these patients have developed preexisting renal disease which was 
worsened by their developing benign prostatic hyperplasia. 
 Group N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Preop 
S.creatinine 
Group I 15 1.747 .3021 .0780 
Group II 25 .960 .1258 .0252 
               Table showing mean creatinine levels in preoperative period 
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Comparison of preoperative sodium, potassium values in both 
groups: 
Preop Na values Group I 15 138.13 1.642 .424 
Group II 25 138.48 1.711 .342 
Preop K levels Group I 15 4.693 .3327 .0859 
Group II 25 4.604 .1098 .0220 
Table showing mean preoperative sodium and potassium levels in both groups 
 
         As depicted above, in group 1, the mean sodium value was 138, 
whereas in group 2, the mean sodium value was 138.48. There was no 
significant difference in these two groups. Similarly, the mean 
preoperative potassium levels in both groups were not significantly 
different. 
Cystourethroscopy findings : 
                    
                       Cystourethroscopy findings of prostate and bladder in both groups. 
On cystourethroscopy, out of 40 patients 16 had bilobar and 24 had 
trilobar enlargement. 
Bladder cystoscopy
TriBi
C
ou
nt
14
13
12
11
10
9
8
7
6
Group
Group I
Group II
58 
 
CYSTOSCOPY – BLADDER TRABECULATIONS: 
Group 1: In group 1, out of 15 , 10 patietns had grade 2 trabeculations, 
rest with grade 3 trabeculations. 
                            
               Figure 10. Cystoscopy-Bladder Trabeculations in Group 1 
 
 Group 2 : In group 2, out of 20, 17 patients had grade 2 trabeculations, 
rest with grade 3 trabeculations. 
                                
               Figure 10. Cystoscopy-Bladder Trabeculations in Group 2 
Resection time during surgery : 
          The mean resection time in group 1 was 53 minutes , with a 
standard deviation of 8.8 minutes. In group 2, the resection time was 56 
minutes mean value with a standard deviation of 9.7 minutes. 
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                                Figure 11. Frequency distribution of complications 
     As mentioned above in group 1, out of 15 patients, three people had 
bleeding, one had retention, one perioperative death due to myocardial 
infarction was recorded, one patient had infection.In all the patients with 
bleeding as complication, blood transfusion was given.  Whereas in group 
2,  two people had bleeding out of 25 patients studied. ( 8% compared to 
20% in group 1). When we taken retention, three people have developed 
in group 2. In case of infection, none had developed, compared to one 
patient in renal failure group. Death was not noted in group 2, whereas 
one recorded in group1. 
Post operative values : 
The mean postoperative sodium value in group 1 was 137.53 with a 
standard deviation of 1.995, where as in group 2 it was 137.92. So, not 
much of difference were noted. Similarly, post operative potassium 
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values were in the range of 4.8 in group 1 with a standard deviation of 0.3 
compared to group 2 with a mean of 4.7. 
Serum creatinine levels in group 1 post surgery : 
Mean serum creatinine level in group 1, which was measured at 2nd post 
operative day was 1.6 with a standard deviation of 0.2. Same group who 
had serum creatinine measured at 14th Post operative day had a mean of 
1.56, and at 6 weeks maintained at a mean of 1.56. This shows there was  
a drop in serum creatinine values post surgery. 
Analysis of various factors : 
Analysis of  variation in serum sodium levels and potassium in  
preoperative and postoperative setting : 
GROUP 1 : 
 Mean N Std. Deviation Std. Error Mean 
Preop Na 
values 
138. 15 1.642 .424 
Post op Na 
values 
137.53 15 1.995 .515 
Preop K levels 4.693 15 .3327 .0859 
Post op K 
levels 
4.800 15 .3359 .0867 
Table showing preoperative and postoperative sodium and potassium levels in Group 
1 patients 
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As depicted in the above table the preoperative sodium and postoperative 
sodium in group 1, was 138 and 137.53, respectively. Similary with 
potassium it was 4.6 and 4.8 respectively. 
When analysed with paired samples test, both of them were insignificant, 
meaning no significant difference in the values noted in the elevated renal 
parameters group. 
GROUP 2: 
 Mean N Std. Deviation 
Std. Error 
Mean 
Pair 1 Preop Na 
values 
138.48 25 1.711 .342 
  Post op Na 
values 
137.92 25 1.730 .346 
Pair 2 Preop K 
levels 
4.604 25 .1098 .0220 
  Post op K 
levels 
4.708 25 .1498 .0300 
    
Table showing preoperative and postoperative sodium and potassium levels in  
                                                  Group  2 patients 
        Similarly,  in group 2 the difference in the values in the preoperative 
and postoperative period was not significant. 
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Serum creatinine values preoperative period and after 6 weeks post 
transurethral resection comparison : 
 Mean N Std. Deviation 
Std. Error 
Mean 
Pair 1 Preop 
S.creatinine 
1.714 14 .2852 .0762 
S.creatinine  
6 weeks 
1.5643 14 .25603 .06843 
Table showing mean S.creatinine improvement in patients in  preoperative period and post operative period 
As mentioned above , the fall in serum creatinine between the time of 
presentation and post operative period, was significant. This implies that 
Transurethral resection has made a positive outcome in this group of 
patients. 
        
 
 Paired Differences t df Sig.  
  Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference      P value 
        Lower Upper       
 Preop 
S.creatinine 
- 
S.creatinine 
6 weeks 
.1500 .10919 .02918 .0870 .2130 5.140 13 .000 
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                                  DISCUSSION 
Benign Prostate Hyperplasia (BPH) is a common disease in ageing 
men with a prevalence of 50% above 50 years and increasing up to 80% 
in men above 80 years. In our institute it was observed that many patients 
who presented with obstructive Lower Urinary Tract Symptoms 
secondary to BPH had associated renal failure.  
While the underlying mechanism for developing renal failure 
associated with BPH is multifactorial and co-morbid factors such as 
diabetes, hypertension, etc in elderly men may contribute to renal 
impairment, we wanted to evaluate the morbidity and mortality and 
outcome in  patients undergoing transurethral resection with nondialysis 
requiring renal failure. 
 Despite the many possible causes of renal failure in elderly 
patients, the common causes were BPH (38%), neurogenic bladder(19%), 
obstructive pyelonephritis (15%). If we have to go by the natural history 
of the disease progression of BPH 13.6% of patients who presented to 
undergo TURP were in renal failure.  
Attending to high prevalence of BPH in older men with renal 
failure it is invaluable to take into consideration the relationship between 
these two clinical entities. However, despite the high prevalence of renal 
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failure and BPH in elderly men, there is very limited knowledge on the 
association between these two conditions and it is important to discuss 
the relationship between BPH and renal failure. 
 We decided to study the association of BPH with renal failure and 
role of TURP which is the gold standard surgery for BPH and its 
associated outcome, morbidity and mortality. A similar study determining 
the role of TURP in management of BPH Presenting with Renal Failure 
was taken up by Thomas et.al.55  
In our study the mean incidence of BPH with renal failure was 12.5%, 
(61/350patients) which was comparable with the other studies. The 
AHCPR BPH Guidelines report a mean of 13.6% of renal failure. In 
another study there was a reported incidence of 11% in patients with renal 
failure secondary to BPH.55  
Since renal failure is a multifactorial process making it harder to 
investigate the true influence of BPH on renal failure, the study was 
designed such that patients who had renal failure associated with benign 
hyperplasia of prostate, after excluding cases of prostatic malignancy, 
other causes of obstructive uropathy,as found that only 20 out of these 
350 patients satisfied our inclusion criteria. 
In our study the average age of presentation was 65 yrs and the 
majority of patients in their sixth decade. Both diseases are extremely 
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common among aging male, leading some to suggest that it is a natural 
concomitant of aging.8 
It is known that age is a independent risk factor for renal 
insufficiency irrespective of medical co-morbidities due to age related 
nephron loss and age is also risk factor for the development of BPH. Both 
diseases are extremely common among aging male, leading some to 
suggest that it is a natural concomitant of aging.8There was a cross-
sectional association between signs and symptoms of bladder outlet 
obstruction and chronic kidney disease in community-dwelling men.(9) In 
contrast, a population-based study from Austria there was no significant 
association between degree of LUTS and GFR after adjusting for age in 
this cross sectional study.(10) In our study severity of LUTS did affect the 
final outcome, however this could be confounded by other risk factors 
such as age, severity of renal failure, degree of bladder dysfunction etc. 
 More recently a cross-sectional survey in Spain of 2,000 randomly 
sampled men who were 50 years or older showed a 2.4% prevalence of 
self-reported renal failure related to a prostate condition (9% reported 
renal failure from any cause).63,9 Another study21 showed that men 
presenting for prostate surgery had a 7.7% prevalence of renal failure 
compared to a 3.7% prevalence in age matched men presenting for 
nonprostate surgery.  
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 Among patients who presented to us 15 patients (50%) were in 
acute retention of urine, 30% were in chronic retention and the remaining 
had severe obstructive voiding symptoms.  
 In acute retention of urine there is rapid progression of renal 
failure due to defect in renal tubular function and most of the cases 
recover well following catheterisation unless they are in acute on chronic 
retention of urine where in patients take a longer time for their renal 
functions to recover while few cases may go into a state of refractory 
renal failure. 
All the patients had an IPSS suggestive of severe lower urinary 
tract symptoms  with bothersome quality of life score being unhappy and 
it was also observed that major contribution in their IPSS were from 
obstructive symptoms as compared to irritative voiding symptoms. 
 In BPH, symptoms results from the direct bladder outlet 
obstruction (BOO) from enlarged tissue (static component) and the 
increased smooth muscle tone and resistance within the enlarged gland 
(dynamic component). These physiologic issues reflect in voiding 
dysfunctions, that significantly affects the health and quality of life of 
many older men. 
Although signs and symptoms of BPH are normally present, there 
are a significant number of patients that are relatively asymptomatic(35) 
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(without significant voiding dysfunction), but can present primarily as 
clinical sequel of renal insufficiency –uremia; with nausea, vomiting and 
mental status changes – and analytical changes –electrolyte disturbances 
(hypercalcemia and nonanion gap acidosis). 
Older patients with voiding dysfunctions caused by chronic urinary 
obstruction might present with hypertension due to hypervolemia in the 
case of bilateral obstruction or increased renin release. Hypertension, on 
other hand can be itself the sole cause of renal failure.35 
In our study serum creatinine (SC) and creatinine clearance(Cr.Cl) 
were taken as criteria for defining renal insufficiency. Serum creatinine of 
1.4mg/dl were taken as the cut-off, a value above which were included in 
the study.  The routine measurement of serum creatinine levels is not 
indicated in the initial evaluation according to the AUA Guideline 
Management of BPH (AUA 2010 Guidelines). This recommendation is 
based on the conclusion that baseline renal insufficiency appears to be no 
more common in men with BPH than in men of the same age group in the 
general population.In our study routine screening of serum creatinine not 
only identified patients with renal failure but also was found to be a 
significant risk factor for causing complication. 
 Coming to the comorbidities, nine patients out of 20 people 
enrolled under elevated renal parameters group had hypertension, 
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diabetes or both. This was not significant when compared to the normal 
group.  
We grouped patients with elevated renal parameters and 20 patients 
were enrolled into group 1. Selected patients underwent cathetrisation, 
post catheterisation serum creatinine values settled. All our patients who 
came to our outpatient department underwent urinary diversion in the 
form of urethral catheterization, subsequently underwent TURP after 
stabilisation of renal functions & once the patient was medically fit to 
undergo TURP.  In five patients serum creatinine values normalized 
below 1.4, hence they were shifted to group 2. Many of the patients 
presented with marginal elevation of serum creatinine indicating early 
renal insufficiency, this could be attributed to severity of symptoms and 
acute retention of urine forcing them to seek medical attention.. 
Following TURP the outcome and complications were analyzed. A 
positive outcome was defined as restoration of normal voiding pattern (as 
reflected by post void residual urine measurements); improvement in the 
renal function, and those who did not satisfy above definition were 
regarded as complications or negative outcome. 
It was found that there was a statistically significant (p 
value=0.000) improvement in serum creatinine and post void residual 
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urine  in the post TURP period suggesting that TURP had a very 
significant role in modifying these factors. 
 We further analysed these factors, some patients whose serum 
creatinine did not touch the baseline, had comorbidites, which might 
suggest that the patients can have a preexisting renal disease, which was 
further worsened by benign hyperplasia of prostate. 
            The mean prostate volume in both groups was not significantly 
different, both ranging from 42 to 46 cc volume. The resection time was 
also not very different between both groups ranging from 52-55 minutes. 
Mean difference in the levels of sodium, potassium were not significant 
in both groups in preoperative and postoperative period. No incidence of 
TURP syndrome was noted in our study. In our study there was no 
association found between volume of prostate gland with final outcome. 
Previous studies which examined the association between prostate size 
and renal function gave conflicting results9 some showing a strict relation 
between prostate size and GFR65 but other studies did not.66 Recent 
studies were made to relate prostate size and LUTS in BPH. Hassanzadeh 
et. al,20 found a significant correlation between urgency and prostate size, 
which can be considered as predictive factor for the disease and probably 
a strong link between BPE and CKD. 
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             In other studies, it was shown that patients with BPH and renal 
insufficiency have much higher postoperative complications (25% 
complication rate compared with 17% for patients without the condition) 
and mortality (up to sixfold) than those with normal renal 
function.37,38,39Comparing the complications between two groups, it was 
found that eventhough complications like bleeding was higher than the 
normal group including need for blood transfusion, they were not 
statistically significant. This may be attributable to the small sample size 
on the study point of view. The use of continuous-flow resectoscopes, 
nonhemolytic irrigation fluids and decrease in operative time, better 
anesthetic care  due to improving and refining of TUR-P technique in 
time with the increased number of operations performed probably has had 
significant positive effects on TUR-P outcomes. This leads to a decrease 
in complication rate compared to older studies. Death was seen in the 
elevated renal parameter group, none was recorded in group 2. Death in 
this patient, had been due to myocardial infarction. Renal failure patients 
are prone for cardiovascular complications. 
 In our study there was no association found between amount of 
residual urine with final outcome. For years it has been well described 
that large volumes (»300 mL) affect renal function in advanced 
BPH.24,9,12 Recent studies, however, demonstrate that the volume of 
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residual urine (post void) necessary to impair renal function is not that 
elevated. 
LIMITATIONS OF THIS STUDY : 
1. Sample size in the elevated parameters group who underwent 
transurethral resection of prostate is less, which was further 
reduced by patients attaining normalization of creatinine values 
post catheterization who subsequently got shifted to group 2. 
2. This study was conducted in a group of patients with lesser grades 
of chronic kidney disease, thereby excluding patients with higher 
grades of Chronic kidney disease and patients on dialysis. To 
exactly study the impact of transurethral resection  and its 
complications in these important subgroups of patients also 
becomes important. 
3. All the patients who underwent transurethral resection, procedure 
was not done by a single surgeon. As it is a teaching institute, 
variations in technique and time varied between individual 
surgeons.  
4. The fourth limitation was follow up. It was hard to get follow up of 
patients, who often faultered on timely visits to hospital despite 
reminders. 
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CONCLUSION 
 The incidence of renal failure associated with benign prostatic 
hyperplasia in our study was about 12.5%. After excluding patients 
with prostatic malignancy, patients needing dialysis, the study 
group constituted 5%. 
 The age of presentation was around 64-65 years, which also 
coincided with increased prevalence of chronic kidney disease in 
elderly population, who also present with benign hyperplasia of 
prostate. 
 There was no significant variation in preoperative and 
postoperative levels of serum sodium, potassium levels in patients 
with nondialysis requiring renal failure (S.creatinine less than 3), 
when compared to normal patients. 
 Complications of transurethral resection in patients who had 
nondialysis requiring renal failure, was on the higher side. 
Bleeding as a complication requiring blood transfusion was noted 
in 20% of patients compared to normal patients. But overall 
complication rate was not statistically significant. This can be 
attributed either small sample size. Improvement in instruments 
like bipolar resection, use of non hemolytic irrigation solutions, 
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continuous flow resectoscopes, better anesthetic care can be a 
factor. 
 The outcome following TURP was successful with restoration in 
normal renal function and normal voiding pattern in majority of  
patients and it was further noted that the successful outcome of  
TURP in these patients were influenced by various factors such as 
age, duration of symptoms, severity of  lower urinary tract 
symptoms, severity of renal failure at the time of presentation, The 
size of Prostate gland had no correlation with the final outcome.  
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ANNEXURE 
PROFORMA 
 
1.     Name: 
2.      Age:                                       
3.      Sex: 
4.      Address: 
 
CHIEF COMPLAINTS: 
 LUTS 
 IPSS                         
 Acute /chronic  retention of urine 
 Abdominal pain 
 Fever and chills (if there is also a urinary tract infection) 
 Uremic symptoms 
PAST HISTORY:  Any associated systemic diseases 
TREATMENT HISTORY/ PREVIOUS OPERATIVE HISTORY 
     
GENERAL PHYSICAL EXAMINATION:  
 
Vitals  
Pallor  
Edema  
SYSTEMIC EXAMINATION:    
 
       Per ABDOMEN 
   
       Per RECTAL: 
 
       EXTERNAL GENITALIA: 
      
       NEUROLOGICAL EXAMINATION 
       
       OTHER SYSTEMS:  
 
INVESTIGATIONS:  
 
Hb,TC, DC  
Urine routine 
 
5.     Date of admission: 
6.     Date of discharge: 
7.     IP NO: 
 
BT/CT/PT 
Blood group 
HIV 
HbsAg 
ECG 
Chest X ray 
 
  
RBS 
Blood Urea 
Sr. creatinine,Sr.Electrolytes 
 
Imaging KUB:  
 Upper Tract 
 Bladder 
 Prostate 
 Pre/Post void  
 Other findings  
Sr.PSA and Prostate Biopsy(Selected cases)    
Urodynamics (Selected cases): 
 
Post urinary  
diversion 
Blood urea  Serum 
creatinine 
Serum 
electrolytes 
 
USG-Upper 
tract status 
Day      
Day      
 
OPERATIVE PROCEDURE:     
    
Type of Operative procedure done                                                              
Date and time: 
    
Findings 
     
Histopathology   
    
FOLLOW-UP 1 week 2 weeeks 
 
6 weeks 
SYMPTOMS 
 
RENAL 
FUNCTIONS 
(S.creatinine) 
  
 
POST-OP 
IMAGING 
(USG KUB) 
  
 
 
  
                  ேநாயாளக¶tகான ஆேலாசைன 
 சி²நƫ வ¯ தாைரய பராேடy எ}§ ரப உள¢. அ¢ 
ெபா¢வாக வயதானவƫக¶t ெபƬயதா வளர வா~© உz.  
 
 இதனா சி²நƫ கழி~பதி சிரம ம² அைட~© ஏபட வா~© 
உz. இைத ம¯|தினா ண~ப{தாம ேபா பyச{திேலா 
அல¢ அtக அைட~©, க, சி²நரக பாதி~©, சி²நƫ கி¯மி ெதா², 
ேபா}றைவ ஏப ேபா¢ அைத அகற ேவzய கyடாய 
ஏபகிற¢. இ{¢ட} வ¯ ேநாயாளகள சில¯t சி²நரக பாதி~© 
ஏபy உ~© ச{¢ உடப அதிகமாக ஆவ¢ உz. எனேவ உ~© ச{¢ 
அதிகமாக உளவƫக¶t உ~© ச{¢ சƬயான அளவ 
உளவƫக¶t, பராேடy ரப அக² ேபா¢  ஏப 
வைளºக பறி நா} ஒ¯ ஆº ேமெகாz உேள}. 
 
 இ|த கzகாணtக~பyட ம¯{¢வ ஆவ தாuக¶ பதிº 
ெச¢ தuகள¢ «¸ ஒ{¢ைழ~ைப நமா² தuகைள அ}©ட} 
ேகyெகாகிேற} . 
                            ேநாயாளக ஒ~©த  
 இ|த ேநா, அதtகான பƬேசாதைன  ம² நட{த~ப ஆைவ 
பறி «¸ைமயாக ம¯{¢வƫ வளtகினாƫ. நா} இ|த ஆவ 
பuெகtக «¸ மன¢ட} சமத ெதƬவகி}ேற} . 
   
                                           
                                            ேநாயாளய} ைகெயா~ப   
 
  
அ§~©னƫ 
        ெபயƫ                 : 
        த|ைத ெபயƫ          :    
        «கவƬ               :         
        வய¢                 :     
ெப²நƫ 
 
 
ஐயா, 
    நா} ேமெசா}ன «கவƬய வசி{¢ வ¯கிேற}.தேபா¢ .....................................  
ெதாழி ெச¢ வ¯கிேற}. எனt சி²நƫ கழி~பதி சிரம, அைட~©, அtக கழி{த 
ேபா}ற ெதா|தரவகாக டா}லி ம¯{¢வமைன வ|¢ேள}. எ}ைன 
பƬேசாதி{த ம¯{¢வƫ எனt  பராேடy ரப ெபƬயதாக உளதாகº, அத 
ஆபேரஷ} ெசய ேவzய அவசிய{ைத வளtகிறினாƫ. இ|த ேநாைய பறிய 
ச|ேதககuகைள நா} ேகyக வளtகினாƫ.இ|த ஆபேரஷ} த}ைம,பtக ம² ப} 
வைளºகைள­ ம¯{¢வƫ வளtகினாƫ.  
.          இ|த ஆவனா எனt, ெபா¢வாக பராேடy ேநாயாளக¶t 
கிைடtக ய ந}ைமக எனt எ{¢ைரtக~பyடன. இ|த ஆº றி{¢, நா} 
எ¸~பய வனாtக ம² ச|ேதகuக¶t ம¯{¢வƫ வளtகமாக பதிலள{தாƫ. 
இவைற ெதƬ|¢ ெகாzட நா} என¢ ய நிைனºட} இ|த ஆவ பuேகக என¢ 
வ¯~ப{தி}ேபƬ யா¯ைடய நிƫப|த« இலாம எ} ய நிைனºட} இ|த 
ஆவ பuேகக என¢ வ¯~ப{ைத ெதƬவ{¢tெகாகிேற}. இ|த ஆº, 
எ}§ைடய, ம² எ} ேபா}ற ேநாயாளயƫ நல} க¯திேய ெசய~பகிற¢ எ}பைத 
அறி|ததா இத எ}ைன ஆyபட¢கி}ேற}. 
இ|த ஆº றி{¢ «¸ வவரuகைள நா} ேகy ெப²ளதா´, எ}§ைடய 
வ¯~ப{தி}ேபƬ பu ெகாவதா´, இ¢ றி{¢ எ|த ற «ைறயyைட­ 
ம¯{¢வƫ மேதா, ஏைனய ம¯{¢வ ஊழியƫக மேதா, ம¯{¢வமைன மேதா எ|த 
நிைலய´ ைவtக மாyேட}. இைதேய எ}§ைடய ஒ~©த ம² ேவzேகா 
கதமாக ஏ²tெகா¶மா² ேகytெகாகிேற}.   
                                                       ேநாயாளய} ைகெயா~ப          
  
பராேடy ஆபேரஷ} ெசவதா - உ~© ச{¢ சƬயான 
அளவ ம² அதிகமாக உளவƫகள ஏப மா²பா 
ம² வைளºக பறிய ஆº                  
ேநாயாளய} ஒ~©த பவ 
ஆராvசி நிைலய                            : அர டா}லி ம¯{¢வமைன, ெச}ைன 600001 
பu ெப²பவƬ} ெபயƫ       :  
பu ெப²பவƬ} ைகெயா~ப : 
பu ெப²பவƫ இதைன (     )  றிtகº 
 
ேமேல றி~பyள ம¯{¢வ ஆவ} வவரuக எனt வளtக~பyட¢.   
எ}§ைடய ச|ேதகuகைள ேகyகº, அதகான  த|த வளtகuகைள  
ெபறº வா~பளtக~பyட¢ . 
 
நா} இ|த  ஆவ த}னvைசயாக{தா} பuெப¯கிேர} .எ|த       
காரண{தினாேலா எ|த சyடசிtகக¶t உyபடாம நா} இ|த  
ஆவ இ¯|¢ வலகிtெகாளலா எ}² அறி|¢ ெகாzேட}. 
 
இ|த ஆº சப|தமாகேவா, இைத சாƫ|த ேம´ ஆº ேம 
ெகா¶ ேபா¢ இ|த  ஆவ பuெப² ம¯{¢வƫ எ}§ைடய  
ம¯{¢வ அறிtைககைள பாƫ~பத எ} அ§மதி ேதைவயைல  
என அறி|¢ெகாகிேற}.நா} ஆவ இ¯|¢ வலகிtகிெகாzடா´ இ¢  
ெபா¯|¢ என அறி|ேத}. 
 
இ|த ஆவ} ¬ல கிைடt தகவகைள­ , பƬேசாதைன  
«ºகைள­, ம² சிகிvைச ெதாடƫபான தகவகைள­ 
 ம¯{¢வƫ ேமெகா¶ ஆவ பய}ப{திtெகாளº அைத 
 பரƬtகº எ} «¸ மன¢ட} சமதிtகிேற}.              
 
இ|த ஆவ பu ெகாள ஒ~©tெகாகிேற}. எனt ெகாtக~பட  
அறிºைரகள} ப நட|¢ ெகாவ¢ட} இ|த ஆைவ ேமெகா¶ 
  
 ம¯{¢வ அணt உzைம­ட} இ¯~ேப} எ}² உ²தி 
 அளகி}ேற}. எ} உட நல பாதிtக~பyடாேலா அல¢ எதிƫபாராத, 
 வழtதிƫtமாறன ேநாtறி ெத}பyடாேலா உடேன அைத 
 ம¯{¢வ அணt ெத¯வ~ேப} என உ²தி அளtகிேற}. 
 
இ|த ஆவ எனt ர{த, சி²நƫ, எtேர, ேக}, உyபட  
அைன{¢ பƬேசாதைனகைள­ ெச¢ ெகாள நா} «¸  
மன¢ட} சமதிtகிேற}. 
 
 
பuேகபவƬ} ைகெயா~ப....................................................இட.....................ேததி ................... 
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Name
ID
Age(yrs)
IPSS scoring
comorbities
usg prostate size
residual urine
S.creatinine at presentation
Preop S.creatinine
Preop Na values
Preop K levels
Bladder cystoscopy
cys-trab
Resection time in min
Preop Hb levels
Post op hb
Post op Na values
Post op K levels 
Post op Creatinine levels
need for blood transfusion
Complications
S.creatinine 2nd day
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S.creatinine 7 th day 
Post op PVR
S.creatinine 6 weeks 
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KEY TO MASTER CHART 
 
 
Bi  - Bilobar 
Exp   - Expired 
He   - Haemorrhage 
Refr  - Refractory renal failure  
Retn  - Retention  
T2  - Trabeculation grade II 
T3  - Trabeculation grade III 
Tri  - Trilobar 
DM                -            Diabetes Mellitus 
HTN               -            Hypertension 
